Introduction of the revolutionary Nanowell-based digital PCR (dPCR)
With up to 8,500 individual PCRs per sample, exceptional sensitivity and accuracy are achieved, which is invaluable for diagnostics and research.
We are proud to be one of the few plant analysis laboratories to offer this unique PCR method as a full service.
Designation as a closed system
IDENTXX GmbH has been successfully recognized as a closed facility or quarantine station pursuant to Article 60 for work pursuant to Articles 8, 48, 49 and 58 of Regulation (EU) 2016/2031.
Portfolio expansion | Marker-based selection
In addition to traditional phenotypic selection, modern plant breeding increasingly relies on molecular methods. IDENTXX supports grapevine breeders with the analysis of genetic markers for the development of fungus-resistant grapevines
Portfolio expansion | RNA analysis
In modern plant research, questions surrounding gene expression and transcript analysis are becoming increasingly important. Therefore, IDENTXX GmbH has consistently expanded its range of methods in this direction.
Unique based on experience!
DNA analysis of large-volume samples (> 1 g of material input) is a unique methodological achievement of IDENTXX GmbH. This allows, for example, the quantitative testing of sheet samples of wheat, barley, corn, or rapeseed for pathogens.
IDENTXX GmbH – Research spirit becomes entrepreneurial reality
After a three-year intensive concept phase, the idea became an operational company.
In addition to moving to Maybachstrasse 50 in Stuttgart, the range of services was expanded to include resistance analysis of arable weeds. To reflect this new direction, PathoScan GbR became IDENTXX GmbH.
Since that time, Dr. Frank Brändle has been a driving force in the role of Managing Partner.
PathoScan GbR - Proof of concept of the idea
The guiding principle of offering tailored molecular services for plant production began with the development of an initial pilot project for the PCR-based detection of downy mildew fungi. The concept impressed the jury of the state funding program "Young Innovators" of the Ministry of Science, Research and the Arts Baden-Württemberg. The funding commitment enabled the founding of PathoScan GbR, based at the University of Hohenheim.
